So essentially your BUY case for IPD is reliant upon the litigation culture of the US, rather than any benefits for patients?
Ann: New Clinical Practice Guidance Recommends Use of BIS, page-30
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
0.001(1.28%) |
Mkt cap ! $159.8M | |||
| Open | High | Low | Value | Volume |
| 7.9¢ | 7.9¢ | 7.7¢ | $76.67K | 981.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 290707 | 7.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 121040 | 1 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.9¢ |
Change
0.001 ( 2.60 %) |
||||
| Open | High | Low | Volume | ||
| 7.8¢ | 8.0¢ | 7.8¢ | 270459 | ||
| Last updated 15.59pm 29/05/2024 ? | |||||
| IPD (ASX) Chart |